In the already mentioned study by Marahatta on a small group of subjects from Thailand [38], authors found a significantly higher gene frequency of the GSTO1*A140D variant (heterozygous or homozygous carriers) in breast cancer patients, as compared to the control group. Here, GSTO1 is linked to breast carcinoma.